Testing Status of Retinoid project 1 M930087
CASRN: RETINOID1
Related: SEE RETINOID PROJECT 2
Secondary:
- 514-78-3 - Canthaxanthin
- 65646-68-6 - 4-(Hydroxyphenyl)retinamide
- 65646-68-6 - Retinoid project 2 (4-(Hydroxyphenyl)retinamide)
- 127-47-9 - Retinoid project 3 (Retinol acetate)
- 65646-68-6 - Retinoid project 4 (4-(Hydroxyphenyl)retinamide)
- 65646-68-6 - Retinoid project 5 (4-(Hydroxyphenyl)retinamide)
- 65646-68-6 - Retinoid project 6 (4-HPR)
- 127-47-9 - Retinol acetate
- 68-26-8 - All-trans retinol
Short-Term Toxicity
- 26 weeks (Dosed-Feed)
(C93028)
Completed
- Citation: Rao G, Ney E, Herbert R. Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene. Breast Cancer Research and Treatment 58:241-254. (2000)
- Citation: Rao G, Ney E, Herbert R. Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Research and Treatment 48:265-271. (1998)
- Citation: Rao G, Ney E, Herbert R. Influence of Diet on Mammary Cancer in Transgenic Mice Bearing an Oncogene Expressed in Mammary Tissue.
- Mice: MMTV/NEU (Tg.Nk)